Cubist Systematic Strategies, LLC Biocryst Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.13 - $6.79 $3.86 Million - $6.35 Million
935,132 Added 528.02%
1,112,232 $6.87 Million
Q1 2024

May 15, 2024
SELL
$4.89 - $7.65 $4.23 Million - $6.62 Million
-865,812 Reduced 83.02%
177,100 $899,000
Q4 2023

Feb 14, 2024
BUY
$4.98 - $6.77 $1.96 Million - $2.66 Million
392,672 Added 60.39%
1,042,912 $6.25 Million
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $151,196 - $178,461
22,533 Added 3.59%
650,240 $4.6 Million
Q2 2023

Aug 14, 2023
BUY
$6.96 - $8.81 $1.22 Million - $1.54 Million
175,092 Added 38.68%
627,707 $4.42 Million
Q1 2023

May 15, 2023
BUY
$7.94 - $11.84 $3.58 Million - $5.34 Million
451,300 Added 34319.39%
452,615 $3.77 Million
Q4 2022

Feb 14, 2023
SELL
$10.5 - $14.2 $2.07 Million - $2.79 Million
-196,728 Reduced 99.34%
1,315 $15,000
Q3 2022

Nov 14, 2022
BUY
$10.79 - $14.81 $1.71 Million - $2.35 Million
158,821 Added 404.93%
198,043 $2.5 Million
Q2 2022

Aug 15, 2022
SELL
$7.89 - $17.88 $890,402 - $2.02 Million
-112,852 Reduced 74.21%
39,222 $415,000
Q1 2022

May 16, 2022
BUY
$11.56 - $19.76 $1.66 Million - $2.83 Million
143,375 Added 1648.18%
152,074 $2.47 Million
Q4 2021

Feb 14, 2022
SELL
$11.18 - $15.46 $547,361 - $756,906
-48,959 Reduced 84.91%
8,699 $120,000
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $166,200 - $206,434
-11,696 Reduced 16.86%
57,658 $829,000
Q2 2021

Aug 16, 2021
BUY
$9.5 - $17.24 $265,145 - $481,168
27,910 Added 67.34%
69,354 $1.1 Million
Q1 2021

May 17, 2021
SELL
$7.37 - $13.61 $3.06 Million - $5.65 Million
-415,120 Reduced 90.92%
41,444 $421,000
Q4 2020

Feb 16, 2021
BUY
$3.37 - $8.61 $1.5 Million - $3.83 Million
444,949 Added 3830.81%
456,564 $3.4 Million
Q3 2020

Nov 16, 2020
BUY
$3.43 - $5.53 $37,438 - $60,359
10,915 Added 1559.29%
11,615 $40,000
Q2 2020

Aug 14, 2020
SELL
$1.9 - $5.61 $35,910 - $106,029
-18,900 Reduced 96.43%
700 $3,000
Q1 2020

May 15, 2020
BUY
$1.6 - $4.11 $27,200 - $69,870
17,000 Added 653.85%
19,600 $39,000
Q4 2019

Feb 14, 2020
BUY
$1.59 - $3.45 $4,134 - $8,970
2,600 New
2,600 $9,000
Q3 2019

Nov 14, 2019
SELL
$2.5 - $3.73 $67,540 - $100,769
-27,016 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$2.91 - $9.15 $46,338 - $145,704
15,924 Added 143.56%
27,016 $102,000
Q1 2019

May 15, 2019
BUY
$7.38 - $9.72 $8,523 - $11,226
1,155 Added 11.62%
11,092 $90,000
Q4 2018

Feb 14, 2019
SELL
$6.51 - $9.6 $51,800 - $76,387
-7,957 Reduced 44.47%
9,937 $80,000
Q3 2018

Nov 14, 2018
BUY
$5.52 - $7.99 $20,390 - $29,515
3,694 Added 26.01%
17,894 $137,000
Q2 2018

Aug 14, 2018
BUY
$4.6 - $6.52 $65,319 - $92,584
14,200 New
14,200 $81,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email